Event & Seminar

[For Korean Partners] Institut Pasteur Korea Drug Discovery Screening Collaboration 2015

2015-04-24


[For Korean Partners] Institut Pasteur Korea Drug Discovery Screening Collaboration 2015

Purpose

- Screen small molecule libraries, identifying and developing new drug candidates
- Combine in a synergistic fashion Institut Pasteur Korea’s proprietary platforms and resources including its screening technology with an innovative phenotypic cell-based assay of Korean Academia
- First in class and best in class compounds may be pursued without any restrictions to the disease field.

Applicant Eligibility
Professors and/or researchers in domestic academia, including those in national, public, governmental and private research institutes/centers working in the life sciences area and whose research conforms with the purpose of the call

Evaluation Procedure
Each full application is reviewed by members of the Drug Discovery Committee (DDC) composed of various experts in translational research and drug development. Applicants who are selected after the submitted proposal review will be notified by May 29 2015. Selected applicants will then be required to prepare and give an oral presentation on their submitted project before the DDC.  Final selection will be announced on June 30 2015.

Please find further information from the flyer above and contact us for any inquiries.
Research Technology Management, Institut Pasteur Korea        
Tel. : (031) 8018-8031
Email : opencall@ip-korea.org